The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
AM23-TU-05-O: Use of Apheresis Modalities for the Management of Solid Organ Transplant Rejection (Enduring)
Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)
$3000
Standard Price
Members save $5
Therapeutic apheresis modalities, including therapeutic plasma exchange and extracorporeal photopheresis (ECP), are increasingly being utilized as part of the multidisciplinary care of solid organ transplant recipients. This session will compare and contrast different treatment regimens currently employed for preventing and treating solid organ transplant rejection. We will review the indications for initiating treatment with apheresis and the impact on patient outcomes. We will review the pathophysiology of organ rejection and more recent data on using ECP to induce organ tolerance. We will highlight ECP's role in managing chronic lung allograft rejection.
Learning Objectives
Describe the pathophysiology of organ rejection, therapeutic options, and proposed mechanisms of action of extracorporeal photopheresis and therapeutic plasma exchange
Contrast different treatment protocols using therapeutic plasma exchange and extracorporeal photopheresis in the management solid organ transplant rejection
Compare outcomes of apheresis-based regimens in the treatment of organ rejection
Examine the data supporting the ability of extracorporeal photopheresis to induce organ tolerance
Recognize the emerging role of extracorporeal photopheresis in the treatment of chronic lung allograft rejection (CLAD)
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM23-TU-05-O: Use of Apheresis Modalities for the Management of Solid Organ Transplant Rejection (Enduring) Evaluation
The future of the blood and biotherapies fields depends on our ability to prepare a new generation of leaders and skilled professionals to continue advancing the field…
Many blood operators around the world are implementing individualized donor assessments that welcome more trans, non-binary, and gender-diverse people to donate…
Come join the party as we celebrate the coming of age of pediatric transfusion medicine (PTM). This session will provide a montage of the superheroes and their influence and impact on mentees and PTM over the past 3-4 decades…